Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Innovatus Pledges $42M to PGDx to Support IVD Development

Innovatus Pledges $42M to PGDx to Support IVD Development

Oct 04, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Investment firm Innovatus Capital Partners said today that it has entered into a financing agreement with Personal Genome Diagnostics, providing up to $42 million in capital to support the company's efforts to advance in vitro diagnostics for genomic testing in cancer patients.

The investment firm didn't disclose further terms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. US to Distribute 150 Million Abbott SARS-CoV-2 Antigen Tests at No Cost

  2. Quotient Limited Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

  3. LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

  4. Zymo Research Gets CE-IVD Mark for Sample Collection Devices

  5. Oxford Immunotec Gets FDA Clearance for TB Test in Patients Aged Two and Older

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.